|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C07K 14/475 |
| (11) | Number of the document | 3212226 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15855147.3 |
| Date of filing the European patent application | 2015-10-29 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/058111 |
| Date | 2015-10-29 |
| (87) | Number | WO 2016/069921 |
| Date | 2016-05-06 |
| (30) | Number | Date | Country code |
| 201462073737 P | 2014-10-31 | US | |
| 201562244604 P | 2015-10-21 | US |
| (72) |
SHEN, Wenyan, US
LINDHOUT, Darrin, US
HALDANKAR, Raj, US
MATERN, Hugo, US
|
| (73) |
NGM Biopharmaceuticals, Inc.,
333 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (54) | COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS |
| COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS |